• Notice of Annual General Meeting in Vivesto AB

    April 8, 2025

  • Report from Annual General Meeting in Vivesto AB

    May 8, 2025

  • Annual report 2024

    April 8, 2025
    (Only distributed in Swedish)

  • First patient dosed in Vivesto’s Paccal Vet dose-finding study in cats

    August 14, 2025

Vivesto licenses Apealea to China’s Zhida Pharmaceutical

March 18, 2025

Interim Report Q2 2025 (in Swedish)

Vivesto published its Q2 report for 2025 on August 12, 2025, at 08.00 am CEST.

The Share

Annual Report 2024